Nice approves first oral treatment with Atogepant that can prevent chronic and episodic migraines
Thousands of people in England who suffer from migraines are to be offered a daily pill on the NHS that can reduce the frequency of attacks by half.
In final draft guidance published on Thursday, the National Institute for Health and Care Excellence (Nice) has given the green light to the first oral treatment that can prevent both chronic and episodic migraines.
